#EADV2025,
LightNews LightNews
medpagetoday.com
GLP-1 agonists appeared to have a bigger impact on the physical and mental health of patients with psoriasis compared with other patients, a large retrospective cohort study showed. #EADV2025
https://www.medpagetoday.com/meetingcoverage/eadv/117593
GLP-1 Drugs Look Good for Psoriasis, Not So Much for Hair
Lower mortality, heart and psychiatric risks in psoriasis, but more evidence of hair loss
www.medpagetoday.com
September 24, 2025 at 2:57 AM
zznyiu.bsky.social
Another bivalent biologic presented at #EADV2025, this time for #atopicdermatitis #eczema - IL-13 and IL17A/F inhibitor Galvokimig in a small phase IIA RCT

potentially very helpful for Asian Th17 AD phenotype or patients at risk of phenotypic switch
September 19, 2025 at 7:23 PM
medpagetoday.com
About 50% more patients with plaque psoriasis had at least 90% skin clearance within 6 months with a novel, once-daily pill as compared with a current standard of care, two randomized trials showed. #EADV2025
https://www.medpagetoday.com/meetingcoverage/eadv/117557
Once-Daily Pill for Psoriasis Gets High Marks in Multiple Studies
Early, durable improvement in skin clearance with novel IL-23 blocker icotrokinra
www.medpagetoday.com
September 20, 2025 at 5:33 AM
medthority.bsky.social
From new approaches in alopecia areata (AA) assessment to emerging agents for hidradenitis suppurativa (HS), catch up on the insights you might have missed at this year’s #EADVCongress with our NEW highlights #MedSky #DermSky #EADV2025

ow.ly/bbzF50X7RSf
October 7, 2025 at 3:30 PM
medthority.bsky.social
❓Where do you stand on PRP for alopecia areata? Promising frontier or premature hype? Join the conversation in the comments below #EADVCongress #EADV2025 #MedSky #DermSky
September 19, 2025 at 10:26 AM
medthority.bsky.social
“We need more drugs” — Ana Giménez-Arnau unpacks CSU endotypes, remission vs relapse, and the evolving landscape of novel therapies for #CSU #EADVCongress #EADV2025 #DermSky #MedSky #Dermatology
September 18, 2025 at 1:37 PM
medthority.bsky.social
Sigall emphasized the importance of standardization: dose, purity, activation, and efficiency of PRP prep all impact outcomes. Without consistency, results can vary widely #EADVCongress #EADV2025 #MedSky #DermSky
September 19, 2025 at 10:26 AM
medthority.bsky.social
Kicking off LIVE coverage of a special session now at #EADVCongress in honour of Marcus Maurer, looking at chronic urticaria and its evolving management landscape #EADV2025 #MedSky #Dermatology #DermSky
September 18, 2025 at 12:15 PM
zznyiu.bsky.social
Probably the closest effort to precision medicine so far in dermatology presented by Michel Gillet - using nanostring measuring gene expression - to differentiate between skin diseases outside of morphology

#EADV2025
September 19, 2025 at 11:31 AM
medthority.bsky.social
The debate reflected a broader tension in dermatology: innovation vs evidence. PRP is biologically plausible and increasingly popular, but is it ready for prime time in AA? #EADVCongress #EADV2025 #MedX #DermSky
September 19, 2025 at 10:26 AM
medthority.bsky.social
If you enjoyed reading through our highlights of the 'Hidradenitis suppurativa' session at #EADVCongress, keep an eye on our #dermatology hub for congress highlights coming soon #EADV2025 #MedSky #DermSky

ow.ly/c8Nv50WYIce
September 18, 2025 at 2:47 PM
medthority.bsky.social
It’s #EADVCongress week! Stay tuned for LIVE updates on alopecia areata, hidradenitis suppurativa, and chronic urticaria. Until then, catch-up with last year’s highlights in our #dermatology hub #MedSky #EADV2025

ow.ly/aUVp50WY9Zy
September 17, 2025 at 2:54 PM
medthority.bsky.social
A fitting tribute to Marcus Maurer at #EADVCongress today with sessions unpacking CSU and CIU, diagnostic challenges and future therapies — his legacy continues to shape chronic urticaria care #EADV2025 #MedSky #Dermatology #DermSky
September 18, 2025 at 1:52 PM
medthority.bsky.social
Wrapping up the #CSU symposium at #EADVCongress with a lively expert panel Q&A. Discussions ranging from clinical challenges to rare links with cancer as a paraneoplastic sign #EADV2025 #Dermatology #MedSky #DermSky
September 18, 2025 at 1:47 PM
medthority.bsky.social
Rakowska countered with caution, highlighting:

💵 High costs

❗Procedural risks

📄Lack of support in contemporary guidelines

Plus, she pointed to British guidance favoring established therapies over PRP #EADVCongress #EADV2025 #MedSky #DermSky
September 19, 2025 at 10:26 AM
medthority.bsky.social
Guidance on diagnosing chronic urticaria from Margarida Gonçalo: Think beyond wheals and “do not forget differential diagnosis”, e.g.

🔹 Normocomplementemic urticarial vasculitis
🔹 Autoinflammatory syndromes
🔹 Bullous pemphigoid

#EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
September 18, 2025 at 1:20 PM
medthority.bsky.social
“No wheals, no diagnosis” — Mojca Bizjak breaks down how to test for symptomatic dermographism and spot key features of cold #urticaria in her presentation on chronic inducible urticaria at #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
September 18, 2025 at 12:57 PM
medthority.bsky.social
LIVE: Martin Metz kicks off the chronic urticaria session in honor of Marcus Maurer with insights on increased mortality in CSU, advances in pathophysiology, and mast cell activation triggers #EADVCongress #EADV2025 #MedSky #Dermatology #DermSky
September 18, 2025 at 12:34 PM
medthority.bsky.social
Sigall started by arguing in favor of PRP, citing:

🩸Capillary formation

🩸Improved nutrient delivery

🩸Anti-apoptotic effects

These mechanisms may support follicle survival and regrowth in AA #EADVCongress #EADV2025 #MedSky #DermSky
September 19, 2025 at 10:26 AM
medthority.bsky.social
That's a wrap! From phenotypes to pregnancy, comorbidities to combined care — #EADVCongress spotlighted the complexity of HS. Early action, holistic strategies, and patient-centred innovation are shaping the future of HS care #EADV2025 #MedSky #Dermatology #DermSky
September 18, 2025 at 2:47 PM
medthority.bsky.social
That’s it for our round-up of one of the many 'Controversies' sessions at this year’s #EADVCongress. For more insights on AA, visit Medthority now for the updates you need to know #EADV2025 #MedSky #DermSky

ow.ly/nJax50WZh7u
September 19, 2025 at 10:26 AM
thejidjournal.bsky.social
Congratulations to Johann Gudjonsson who received the EADV International Award at #EADV2025.
We are very grateful to Johann for his invaluable work as a senior editor of the JID!!
Photo credit: Thy Thy Do
#dermsky #dermatology #dermscience #dermresearch #Skinresearch #psoriasis #atopicdermatitis
September 22, 2025 at 3:38 PM
medthority.bsky.social
What are the key takeaways in #CSU management from #EADVCongress? Catch-up on the updates you need to know, from clinical outcomes in key trials to comparative insights on advanced therapies, with our short summary articles available now #MedSky #EADV2025 #DermSky

ow.ly/P2cf50X0VnN
September 23, 2025 at 3:01 PM
medthority.bsky.social
What were the latest updates on hidradenitis suppurativa (HS) from today’s session at #EADVCongress? From disease forms and comorbidities to disease progression and women’s health, read through our thread below to get closer to the conversations that matter in HS management #MedSky #EADV2025
September 18, 2025 at 2:47 PM
medthority.bsky.social
Platelet-rich plasma (PRP) therapy for alopecia areata (AA) remains one of dermatology’s most debated topics. At #EADVCongress, Daniel Asz Sigall and Adriana Rakowska went head-to-head on its merits and limitations. Catch-up on the debate with our thread below #EADV2025 #MedSky #DermSky
September 19, 2025 at 10:26 AM